SI-BONE Inc

SI-BONE Inc(SIBN)资讯与事件

$20.820

+0.283 (+1.36%)收盘时

SIBN 资讯

SIBN 事件

9/28 16:30

SI-Bone Receives FDA 510(k) Clearance for iFuse Granite Onyx System

SI-Bone announced FDA 510(k) clearance for the iFuse Granite Onyx System. This is SI-Bone's first product addressing the problem of compromised bone which is intended for use outside the pelvis, expanding the market opportunity for the company's 3D-printed bone integration platform.

8/3 17:00

Q2 Revenue of $56.0M Exceeds Consensus

Reports Q2 revenue $56.0M, consensus $55.4M. "Our accelerating growth and expanding profitability reinforces our conviction in the demand for our superior platform technologies and the significant runway ahead," said Laura Francis, CEO. "This quarter's record physician engagement reflects our strategy to develop unique procedural solutions for patients with compromised bone and underscores the meaningful market need we are addressing. We are excited about the upcoming third breakthrough device launch in the fourth quarter, a substantially improved reimbursement backdrop, and an expanding commercial reach. Together, these tailwinds position us to expand adoption, broaden patient access, and enter our next phase of strong, sustainable multi-year revenue growth."

8/3 17:00

Company Maintains FY26 Gross Margin Guidance at ~79%

The company is maintaining FY26 gross margin guidance at ~79%, and updating operating expenses guidance to now be ~12% compared to the prior guidance of ~12.5%.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易